Drug Trial Radar · NCT04479800
Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Aug 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
21
Actual
Start
Jul 20, 2020
Primary completion
Aug 25, 2020
Study completion Aug 25, 2020
Sponsor
- Lead sponsor
- Astex Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 21, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, single-dose, open-label, randomized, three-period, three-way crossover study in which healthy adult participants will receive three separate single-dose administrations of ASTX660 capsules under three different conditions.
Conditions
- Healthy Volunteer
Interventions
ASTX660Drug
Form: capsule; Route of administration: oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetic parameter CmaxTime frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter TmaxTime frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter λzTime frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter t1/2Time frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter AUC(0-24h)Time frame: Predose to 24 hours postdose, up to Day 4
- Pharmacokinetic parameter AUClastTime frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter AUCinfTime frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter AUCExtrap (%)Time frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter ClastTime frame: Predose to 72 hours postdose, up to Day 4
- Pharmacokinetic parameter TlastTime frame: Predose to 72 hours postdose, up to Day 4
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Worldwide Clinical Trials
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.